Kolltveit, Beate-Christin Hope
Oftedal, Bjørg Frøysland
Thorne, Sally
Lomborg, Kirsten
Graue, Marit
Funding for this research was provided by:
Western Norway University Of Applied Sciences
Article History
Received: 22 February 2023
Accepted: 11 February 2024
First Online: 23 February 2024
Declarations
:
: The study has obtained ethical approval from the South-Eastern Norway Regional Committee for Medical and Health Research Ethics (2019/28/REK sør-øst A). The project was carried out in accordance with the Helsinki Declaration and reported in accordance with the COREQ (COnsolidated criteria for REporting Qualitative research) Checklist [CitationRef removed]. Further information can be obtained from ClinicalTrials.gov (ID: NCT04076384). The participants were informed that their participation was voluntary, and that they could withdraw from the study at any time with no consequences. Their anonymity was preserved by using numbers instead of names in all transcripts. The Western Norway University of Applied Sciences is the responsible research institution where we store study data on a secure research server. The principal investigator and some clearly identified members of the project group have access to the data. If some important protocol modifications occur, we would communicate this to the ethics committee and ClinicalTrials.gov.
: All patients interviewed filled out an informed consent form prior to participation.
: Not applicable.
: None declared.
: BCHK and MG applied for funding for this study. BCHK, BFO and MG designed the study with involvement of ST. ASI collected the data. BCHK, BFO, ST, KL and MG contributed to data analysis. BCHK, BFO, ST, KL and MG contributed to drafting the manuscript and read and approved the final manuscript.